Purpose: To describe the interesting and fairly rare due to its features clinical case of secondary glaucoma caused by prolonged use of corticosteroids in the composition of ocular drops and ointments for the treatment of chronic blepharitis. Key points: The features of this case are the young age of the patient, as well as late diagnosis of steroid glaucoma and concomitant systemic disease in the form of psoriatic spondylitis, despite regular examinations of the patient by ophthalmologists from various medical institutions over the past two years in connection with the treatment of chronic blepharitis with frequent exacerbations in both eyes. The abolition of corticosteroid drugs, complex treatment in combination with immunocorrection, systemic therapy of psoriatic spondylitis and surgical treatment of glaucoma in both eyes led to long-term remission of chronic blepharitis, stabilization of the glaucomatous process and improvement of the patient’s quality of life. Conclusion: Ophthalmologists should monitor the level of intraocular pressure in all patients who are treated with drugs containing corticosteroids
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.